143 related articles for article (PubMed ID: 38492862)
1. Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy.
Jiang Y; Zhang Y; Liu C; Liu J; Xue W; Wang Z; Li X
J Control Release; 2024 Apr; 368():663-675. PubMed ID: 38492862
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy.
Liu JQ; Zhang C; Zhang X; Yan J; Zeng C; Talebian F; Lynch K; Zhao W; Hou X; Du S; Kang DD; Deng B; McComb DW; Bai XF; Dong Y
J Control Release; 2022 May; 345():306-313. PubMed ID: 35301053
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of poly(γ-glutamic acid) in lipid nanoparticles for enhanced mRNA delivery efficiency in vitro and in vivo.
Zhang H; Gao X; Sun Q; Dong X; Zhu Z; Yang C
Acta Biomater; 2024 Mar; 177():361-376. PubMed ID: 38342193
[TBL] [Abstract][Full Text] [Related]
6. Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression.
da Silva WN; Carvalho Costa PA; Scalzo Júnior SRA; Ferreira HAS; Prazeres PHDM; Campos CLV; Rodrigues Alves MT; Alves da Silva NJ; de Castro Santos AL; Guimarães LC; Chen Ferris ME; Thatte A; Hamilton A; Bicalho KA; Lobo AO; Santiago HDC; da Silva Barcelos L; Figueiredo MM; Teixeira MM; Vasconcelos Costa V; Mitchell MJ; Frézard F; Pires Goulart Guimaraes P
Int J Nanomedicine; 2024; 19():2655-2673. PubMed ID: 38500680
[TBL] [Abstract][Full Text] [Related]
7. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
[TBL] [Abstract][Full Text] [Related]
8. Delivering mRNA to a human NK cell line, NK-92 cells, by lipid nanoparticles.
Nakamura T; Nakade T; Sato Y; Harashima H
Int J Pharm; 2023 Apr; 636():122810. PubMed ID: 36898618
[TBL] [Abstract][Full Text] [Related]
9. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
Wang C; Zhang Y; Dong Y
Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
[TBL] [Abstract][Full Text] [Related]
10. mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells.
Bevers S; Kooijmans SAA; Van de Velde E; Evers MJW; Seghers S; Gitz-Francois JJJM; van Kronenburg NCH; Fens MHAM; Mastrobattista E; Hassler L; Sork H; Lehto T; Ahmed KE; El Andaloussi S; Fiedler K; Breckpot K; Maes M; Van Hoorick D; Bastogne T; Schiffelers RM; De Koker S
Mol Ther; 2022 Sep; 30(9):3078-3094. PubMed ID: 35821637
[TBL] [Abstract][Full Text] [Related]
11. Efficient delivery of VEGFA mRNA for promoting wound healing via ionizable lipid nanoparticles.
Dong S; Wang J; Guo Z; Zhang Y; Zha W; Wang Y; Liu C; Xing H; Li X
Bioorg Med Chem; 2023 Jan; 78():117135. PubMed ID: 36577327
[TBL] [Abstract][Full Text] [Related]
12. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Tailored Ionizable Lipid Nanoparticles Facilitate IL-12 Circular RNA Delivery for Enhanced Lung Cancer Immunotherapy.
Xu S; Xu Y; Solek NC; Chen J; Gong F; Varley AJ; Golubovic A; Pan A; Dong S; Zheng G; Li B
Adv Mater; 2024 Apr; ():e2400307. PubMed ID: 38657273
[TBL] [Abstract][Full Text] [Related]
14. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery.
Patel SK; Billingsley MM; Mukalel AJ; Thatte AS; Hamilton AG; Gong N; El-Mayta R; Safford HC; Merolle M; Mitchell MJ
Theranostics; 2024; 14(1):1-16. PubMed ID: 38164140
[TBL] [Abstract][Full Text] [Related]
15. STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation.
Nakamura T; Sato T; Endo R; Sasaki S; Takahashi N; Sato Y; Hyodo M; Hayakawa Y; Harashima H
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34215690
[TBL] [Abstract][Full Text] [Related]
16. Engineered mRNA-expressed bispecific antibody prevent intestinal cancer via lipid nanoparticle delivery.
Wu L; Wang W; Tian J; Qi C; Cai Z; Yan W; Xuan S; Shang A
Bioengineered; 2021 Dec; 12(2):12383-12393. PubMed ID: 34895063
[TBL] [Abstract][Full Text] [Related]
17. A Synergistic Lipid Nanoparticle Encapsulating mRNA Shingles Vaccine Induces Potent Immune Responses and Protects Guinea Pigs from Viral Challenges.
Cheng X; Liu S; Sun J; Liu L; Ma X; Li J; Fan B; Yang C; Zhao Y; Liu S; Wen Y; Li W; Sun S; Mi S; Huo H; Miao L; Pan H; Cui X; Lin J; Lu X
Adv Mater; 2024 Mar; 36(13):e2310886. PubMed ID: 38145557
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8
Chen J; Ye Z; Huang C; Qiu M; Song D; Li Y; Xu Q
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207841119. PubMed ID: 35969778
[TBL] [Abstract][Full Text] [Related]
19. Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length.
Mrksich K; Padilla MS; Joseph RA; Han EL; Kim D; Palanki R; Xu J; Mitchell MJ
J Biomed Mater Res A; 2024 Mar; ():. PubMed ID: 38487970
[TBL] [Abstract][Full Text] [Related]
20. Novel Ionizable Lipid Nanoparticles for SARS-CoV-2 Omicron mRNA Delivery.
Long J; Yu C; Zhang H; Cao Y; Sang Y; Lu H; Zhang Z; Wang X; Wang H; Song G; Yang J; Wang S
Adv Healthc Mater; 2023 May; 12(13):e2202590. PubMed ID: 36716702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
